| National News | International News  | Spurious Tuberculosis Drugs Pose a Threat GLOBAL :: TB New York Times (07.01.2013) :: By Donald G. McNeil Jr. | | | Researchers reported that pharmacy sales of substandard TB medications in poor countries could result in a public health crisis. Report author Dr. Amir Attaran, a drug-counterfeiting expert at the University of Ottawa, stated that 9 percent of 713 samples of TB medications purchased in 17 countries contained little or no active ingredient. Medications with too little active ingredient were even more dangerous than those with no active ingredient, as an “inadequate dose” allowed drug-resistant TB strains to develop.
Dr. Lucica Ditiu, executive secretary of Stop TB Partnership, which is affiliated with the World Health Organization, affirmed that the study identified weak points in the TB control system. The Stop TB Partnership packages high-quality TB drugs for approximately $30 per six-month supply. The drugs are free for poor countries and available at a reduced cost for middle-income countries. Attaran urged all countries to follow WHO recommendations, ban sales of TB drugs, and purchase the Stop TB Partnership drugs.
Poor countries such as Rwanda have demonstrated they could control TB through “pharmacovigilance.” India, which has not enforced pharmacovigilance, is now facing a multidrug-resistant TB epidemic.
The full report, “Combatting Substandard and Falsified Medicines: A View from Rwanda,” was published online in the journal PLOS Medicine (2013; doi:10.1371/journal.pmed.1001476).
| Read Full Article | Share this Article  | | Back to Top  |  | | | Medical News | Local and Community News  | HIV: New East Bay Program Gives Prevention Pill to High-Risk Youths CALIFORNIA :: HIV/AIDS San Jose Mercury News (07.15.2013) :: By Sandy Kleffman | | | A new program will provide the drug Truvada to more than 100 East Bay youth along with safe-sex counseling and other sexual health services to prevent HIV transmission. In 2012, the US Food and Drug Administration approved Truvada to help prevent HIV in high-risk healthy individuals. George Lemp, director of the University of California Office of the President’s HIV/AIDS Research Program, cited the frustration with the inability to reduce the number of new infections as the driving force behind the more aggressive method of prevention. The University of California program will award $18 million in grants throughout four years to teams in Oakland, Los Angeles, and San Diego to test this new approach of distributing Truvada to high-risk groups. The Bay Area program will be supervised by the Downtown Youth Clinic, which is part of the East Bay AIDS Center at Alta Bates Summit Medical Center in Oakland.
The program will target 15–29-year-old gay men in cities along the Bay from Richmond through Berkeley, Oakland, and to Fremont. The program will include regular monitoring of participants for adverse reactions to the drug, organizing peer discussion groups, stressing the importance of safe sex, and delivering a variety of sexual health services to young men who often lack healthcare. The drug, which sells wholesale for approximately $46 per daily pill—$1,300 a month—will be free for participants. Drug manufacturer Gilead is donating approximately $20 million worth of the medication to programs in the Bay Area and Southern California. According to Project Director Ifeoma Udoh, program leaders plan to use social media to contact youth and will reach out at schools, parties, and other places where young people congregate. | Read Full Article | Share this Article  | | Back to Top  |  | | | News Briefs | | | | | AIDS Project RI Launches New Website RHOHDE ISLAND :: HIV/AIDS Edge on the Net (07.11.2013) :: By Winnie McCroy | | | AIDS Project Rhode Island (APRI) launched a new Web site to address the health needs of gay and bisexual men. The site, called Men2MenRi.org, will inform its users about how to stay healthy and HIV-free, and provide a forum for them to connect with each other socially. The site resulted from the responses of gay and bisexual men to a statewide survey and features an interactive HIV risk quiz; frequently asked questions on men’s health; lists of HIV test sites; and links to LGBT-friendly healthcare providers such as doctors, dentists, and mental health specialists. The site also includes safe sex information and tips on post and pre-exposure prophylaxis. Dr. Phil Chan, an internal medicine and infectious disease physician at the Miriam Hospital in Providence, will answer site visitors’ questions. The site features resources for those who have not yet dealt with their sexual orientation, a community calendar for groups to post events, and information on how to become an activist, as well as a section called Living with HIV in Rhode Island, where people can share their stories. APRI Executive Director Thomas Bertrand plans to promote the site on college LGBT sites and the state health department’s Web site.
| Read Full Article | Share this Article  | | Back to Top  |  | | |
No comments:
Post a Comment